Literature DB >> 28616117

Periurethral bulking agents for female stress urinary incontinence in Canada.

Adiel Mamut1, Kevin V Carlson1.   

Abstract

Urethral bulking aims to improve urethral mucosal coaptation, and thus outlet resistance, in an effort to limit stress-induced leakage. While efforts have been made to employ bulking agents to treat stress urinary incontinence (SUI) for more than 100 years, we remain wanting for the perfect injectable. Regardless of the agent studied, efficacy is modest at best, repeat injections are the norm, and long-term followup is conspicuously lacking. This treatment, however, fills an important need in our armamentarium against SUI, serving those patients who are not candidates for more invasive interventions and those with multiple prior failed surgeries. This review offers a contemporary discussion on the role of periurethral bulking therapy in Canada, along with practical aspects of its application.

Entities:  

Year:  2017        PMID: 28616117      PMCID: PMC5461150          DOI: 10.5489/cuaj.4612

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  12 in total

1.  Current use of injectable agents for female stress urinary incontinence.

Authors:  Sender Herschorn
Journal:  Rev Urol       Date:  2005

2.  Is injection therapy for stress urinary incontinence dead? No.

Authors:  R Duane Cespedes; Faye B Serkin
Journal:  Urology       Date:  2008-10-01       Impact factor: 2.649

3.  Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically.

Authors:  Deborah Lightner; Eric Rovner; Jacques Corcos; Christopher Payne; Linda Brubaker; Harold Drutz; Gary Steinhoff
Journal:  Urology       Date:  2009-08-05       Impact factor: 2.649

4.  2012 update: guidelines for adult urinary incontinence collaborative consensus document for the canadian urological association.

Authors:  Mathieu Bettez; Le Mai Tu; Kevin Carlson; Jacques Corcos; Jerzy Gajewski; Martine Jolivet; Greg Bailly
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

Review 5.  Urethral injection therapy for urinary incontinence in women.

Authors:  Vivienne Kirchin; Tobias Page; Phil E Keegan; Kofi Atiemo; June D Cody; Samuel McClinton
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

6.  A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere.

Authors:  D Lightner; C Calvosa; R Andersen; I Klimberg; C G Brito; J Snyder; D Gleason; D Killion; J Macdonald; A U Khan; A Diokno; L T Sirls; D Saltzstein
Journal:  Urology       Date:  2001-07       Impact factor: 2.649

7.  Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence.

Authors:  R D Mayer; R R Dmochowski; R A Appell; P K Sand; I W Klimberg; K Jacoby; C W Graham; J A Snyder; V W Nitti; J C Winters
Journal:  Urology       Date:  2007-05       Impact factor: 2.649

Review 8.  Urethral bulking agents: techniques and outcomes.

Authors:  Ahmed F Kotb; Lysanne Campeau; Jacques Corcos
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

9.  Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study.

Authors:  Eric R Sokol; Mickey M Karram; Roger Dmochowski
Journal:  J Urol       Date:  2014-04-02       Impact factor: 7.450

Review 10.  The efficacy and safety of urethral injection therapy for urinary incontinence in women: a systematic review.

Authors:  Priscila Katsumi Matsuoka; Rafael Fagionato Locali; Aparecida Maria Pacetta; Edmund Chada Baracat; Jorge Milhem Haddad
Journal:  Clinics (Sao Paulo)       Date:  2016-02       Impact factor: 2.365

View more
  5 in total

1.  Stress urinary incontinence treatment: Focus should be on identifying best candidates for surgical success in the first place.

Authors:  Shawna Johnston
Journal:  Can Urol Assoc J       Date:  2017-08       Impact factor: 1.862

2.  Stress urinary incontinence and the forgotten female hormones.

Authors:  Nicholas Siddle; Eboo Versi
Journal:  Int Urogynecol J       Date:  2022-04-23       Impact factor: 1.932

3.  Urolastic®, a new bulking agent for treatment of stress urinary incontinence: a systematic review and meta-analysis.

Authors:  Giampiero Capobianco; Antonio Azzena; Laura Saderi; Francesco Dessole; Salvatore Dessole; Giovanni Sotgiu
Journal:  Int Urogynecol J       Date:  2018-06-23       Impact factor: 2.894

Review 4.  The Novel and Minimally Invasive Treatment Modalities for Female Pelvic Floor Muscle Dysfunction; Beyond the Traditional

Authors:  Yiğit Akın; Matthew Young; Muhammad Elmussareh; Nickolaus Charalampogiannis; Ali Serdar Gözen
Journal:  Balkan Med J       Date:  2018-06-28       Impact factor: 2.021

5.  The Role of Gap Junctions in the Generation of Smooth Muscle Cells from Bone Marrow Mesenchymal Stem Cells.

Authors:  Ying Wang; Boping Yang; Pan Hu; Shentao Lu; Li Lei; Lubin Liu
Journal:  Dis Markers       Date:  2022-08-12       Impact factor: 3.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.